PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS.

por Misyurina, A., Kravchenko, S., Magomedova, A., Kovrigina, A., Obukhova, T., Sychevskaya, K., Babaeva, F.
Publicado 2022

P1211: CLINICAL HETEROGENEITY OF HIGH-GRADE B-CELL LYMPHOMA. EDGE OF TRANSFORMATION.

por Misyurina, A., Kravchenko, S., Magomedova, A., Kovrigina, A., Obukhova, T., Sychevskaya, K., Zakharko, E., Rubkina, E., Misyurin, V., Babaeva, F.
Publicado 2022

PB2282: HERPESVIRUSES REPLICATION DURING COVID-19 IN NON-HODGKIN’S LYMPHOMA PATIENTS.

por Sychevskaya, K., Kravchenko, S., Tikhomirov, D., Korneeva, A., Abdulpatahov, A., Abdurashidova, R., Keniaykina, A., Sarakaeva, Z., Tupoleva, T., Misyurina, A., Babaeva, F.
Publicado 2022

PB2089: ALGORITHM FOR SEVERE COVID-19 RISK STRATIFICATION DEPENDING MONOCLONAL ANTI-CD20 ANTIBODIES TREATMENT DURATION IN NON-HODGKIN LYMPHOMA PATIENTS.

por Sychevskaya, K., Kravchenko, S., Babaeva, F., Misyurina, A., Korneeva, A., Abdulpatahov, A., Abdurashidova, R., Keniaykina, A., Sarakaeva, Z., Fastova, E., Gorenkova, L., Nesterova, E., Mangasarova, Y., Bagova, M., Margolin, O., Magomedova, A.
Publicado 2022

P1207: MULTICENTER RANDOMIZED CONTROLLED (COMPARATIVE) OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF THE R-DA-EPOCH-21 AND R-MNHL-BFM-90 ± AUTO- HSCT PROGRAMS IN PATIENTS WITH...

por Magomedova, A., Kravchenko, S., Misyurina, A., Mangasarova, Y., Margolin, O., Fastova, E., Babaeva, F., Gorenkova, L., Bagova, M., Nesterova, E., Sychevskaya, K., Moiseeva, T., Kovrigina, A., Obukhova, T., Dvirnyk, V., Galtseva, I., Galuzyak, V., Maryina, S., Danishyan, K., Kostina, I., Sudarikov, A., Klyasova, G., Kulikov, S., Chabaeva, Y., Zinina, E., Kryuchkova, I., Sizikova, S., Sergeyevicheva, V., Ksenzova, T., Anikina, E., Shelekhova, T., Arzhanukhina, O., Kaplanov, K., Konstantinova, T., Serdyuk, O., Sychyova, T., Chagorova, T., Nechunayeva, I., Anchukova, L., Dzarasova, O., Parovichnikova, E., Savchenko, V.
Publicado 2022